Targeting Cytokines as Evolving Treatment Strategies in Chronic Inflammatory Airway Diseases.
Targeting Cytokines as Evolving Treatment Strategies in Chronic Inflammatory Airway Diseases.
复制标题
DOI:
10.3390/ijms19113402
复制
发表时间:
2018-10-30
影响因子:
5.6
通讯作者:
Krick S
中科院分区:
文献类型:
--
作者:
Garth J;Barnes JW;Krick S
Cytokines are key players in the initiation and propagation of inflammation in chronic inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD), bronchiectasis and allergic asthma. This makes them attractive targets for specific novel anti-inflammatory treatment strategies. Recently, both interleukin-1 (IL-1) and IL-6 have been associated with negative health outcomes, mortality and a pro-inflammatory phenotype in COPD. IL-6 in COPD was shown to correlate negatively with lung function, and IL-1beta was induced by cigarette smoke in the bronchial epithelium, causing airway inflammation. Furthermore, IL-8 has been shown to be a pro-inflammatory marker in bronchiectasis, COPD and allergic asthma. Clinical trials using specific cytokine blockade therapies are currently emerging and have contributed to reduce exacerbations and steroid use in COPD. Here, we present a review of the current understanding of the roles of cytokines in the pathophysiology of chronic inflammatory airway diseases. Furthermore, outcomes of clinical trials in cytokine blockade as novel treatment strategies for selected patient populations with those diseases will be discussed.
登录
查看更多内容
DOI:
10.1073/pnas.0408535102
发表时间:
2005-01-11
影响因子:
11.1
作者:
Bender, AT;Ostenson, CL;Beavo, JA
通讯作者:
Beavo, JA
影响因子:
24.3
作者:
Chalmers, James D.;Aliberti, Stefano;Blasi, Francesco
通讯作者:
Blasi, Francesco
影响因子:
76.2
作者:
Brightling, Christopher E.;Bleecker, Eugene R.;van der Merwe, Rene
通讯作者:
van der Merwe, Rene
DOI:
10.1513/pats.200807-069th
发表时间:
2008-12-01
期刊:
Proceedings of the American Thoracic Society
影响因子:
--
作者:
Barnes, Peter J
通讯作者:
Barnes, Peter J
影响因子:
3.1
作者:
Armstrong, DS;Hook, SM;Grimwood, K
通讯作者:
Grimwood, K